SCH 721015

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SCH 721015, covering 2015-03-27 to 2015-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Tolerability Study of SCH 721015 in Patients With Transitional Cell Carcinoma of the Bladder (Study P03816) [Phase 1]

See pricing